Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications
In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications.
Understanding the Impact of the COVID-19 Pandemic on the Psychological Well-Being of Individuals Undergoing Infertility TreatmentÂ
Women undergoing infertility treatment, as well as women who conceived after infertility, experienced significant levels of distress as a result of the COVID-10 pandemic.
Weekly Roundup for JANUARY 20, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Reassuring Data on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antipsychotic Medications
Two studies - one using neuropsychological assessments, another examining performance on standardized testing - show no association between prenatal antipsychotic exposure and neurodevelopmental outcomes.
Weekly Roundup for JANUARY 13, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants: A look forward – ObGynNews
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants with Ob.Gyn News on August 16,